Paul Statkevich
- Oncology top 1%
- Molecular Biology top 5%
- Genetics top 1%
- Pulmonary and Respiratory Medicine top 2%
- Surgery top 5%
- Co-authors
- Teddy KosoglouDavid L. CutlerKevin B. AltonYali ZhuAmy O. Johnson‐LevonasLarisa ReydermanArthur BergmanJohn F. Paolini
- Topics
- Advanced Breast Cancer Therapies (17 papers)Chronic Lymphocytic Leukemia Research (12 papers)Lipoproteins and Cardiovascular Health (12 papers)
- Cited by
- GeneticsOncologyCancer Research
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Paul Statkevich
91 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Oncology 2.1k
- Molecular Biology 1.6k
- Genetics 980
- Pulmonary and Respiratory Medicine 971
- Surgery 859
Countries citing papers authored by Paul Statkevich
This map shows the geographic impact of Paul Statkevich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Statkevich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Statkevich more than expected).
Fields of papers citing papers by Paul Statkevich
This network shows the impact of papers produced by Paul Statkevich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Statkevich. The network helps show where Paul Statkevich may publish in the future.
Co-authorship network of co-authors of Paul Statkevich
This figure shows the co-authorship network connecting the top 25 collaborators of Paul Statkevich. A scholar is included among the top collaborators of Paul Statkevich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Statkevich. Paul Statkevich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 17 | |
| 3 | 2 | |
| 4 | 105 | |
| 5 | 10 | |
| 6 | 10 | |
| 7 | 40 | |
| 8 | 28 | |
| 9 | 23 | |
| 10 | 14 | |
| 11 | 82 | |
| 12 | 49 | |
| 13 | 13 | |
| 14 | 50 | |
| 15 | 285 | |
| 16 | 89 | |
| 17 | 91 | |
| 18 | Ezetimibe does not affect the pharmacokinetics of oral contraceptives | 27 |
| 19 | High-performance liquid chromatographic determination and stability of 5-(3-methyltriazen-1-yl)-imidazo-4-carboximide, the biologically active product of the antitumor agent temozolomide, in human plasma | 13 |
| 20 | 39 |
About Paul Statkevich
Paul Statkevich is a scholar working on Genetics, Oncology and Hematology, having authored 92 papers that have together received 4.8k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (17 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Lipoproteins and Cardiovascular Health (12 papers). The work is most often cited by research in Genetics (980 citations), Oncology (2.1k citations) and Cancer Research (646 citations). Paul Statkevich has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Teddy Kosoglou, David L. Cutler, Kevin B. Alton, Yali Zhu, Amy O. Johnson‐Levonas, Larisa Reyderman, Arthur Bergman, John F. Paolini, Uwe Fraass and Vijay Batra. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.